U.K. Court Invalidates Merck Fosamax Patents
The English Court of Appeal upheld the English Patents Court's ruling invalidating two Merck patents related to its Fosamax osteoporosis drug, Israeli generics drugmaker Teva Pharmaceutical Industries said Thursday....To view the full article, register now.
Already a subscriber? Click here to view full article